Kodiak Sciences Inc (KOD): Price and Financial Metrics

Kodiak Sciences Inc (KOD): $7.60

-0.14 (-1.81%)

POWR Rating

Component Grades













Add KOD to Watchlist
Sign Up

Industry: Biotech



in industry

KOD Stock Price Chart Interactive Chart >

Price chart for KOD

KOD Price/Volume Stats

Current price $7.60 52-week high $26.39
Prev. close $7.74 52-week low $4.90
Day low $7.34 Volume 396,000
Day high $7.91 Avg. volume 1,521,988
50-day MA $9.85 Dividend yield N/A
200-day MA $9.62 Market Cap 395.50M

Kodiak Sciences Inc (KOD) Company Bio

Kodiak Sciences is a clinical stage biopharma specializing in therapeutics to treat chronic retinal diseases. The company was founded in 2005 and is based in New York City, New York.

KOD Latest News Stream

Event/Time News Detail
Loading, please wait...

KOD Latest Social Stream

Loading social stream, please wait...

View Full KOD Social Stream

Latest KOD News From Around the Web

Below are the latest news stories about KODIAK SCIENCES INC that investors may wish to consider to help them evaluate KOD as an investment opportunity.

Owning 44% shares,institutional owners seem interested in Kodiak Sciences Inc. (NASDAQ:KOD),

If you want to know who really controls Kodiak Sciences Inc. ( NASDAQ:KOD ), then you'll have to look at the makeup of...

Yahoo | September 22, 2022

Why Is Kodiak Sciences Inc. (KOD) Down 23.8% Since Last Earnings Report?

Kodiak Sciences Inc. (KOD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | September 8, 2022

Kodiak Sciences to Present at the 2022 Morgan Stanley Healthcare Conference

Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that management will present at the 2022 Morgan Stanley Healthcare Conference in New York, NY on Wednesday, September 14, 2022, at 1:05 p.m. Pacific Time (4:05 p.m. Eastern Time).

Yahoo | September 7, 2022

Kodiak Sciences (KOD) Rises 60% in Past 3 Months: Here's Why

Kodiak Sciences (KOD) has progressed well with the development of its lead pipeline candidate, tarcocimab, for treating various retinal vascular diseases.

Yahoo | August 26, 2022

Kodiak Sciences (KOD) Focuses on Developing Eye Drug Tarcocimab

Kodiak Sciences (KOD) lead pipeline candidate, tarcocimab, being developed for treating various retinal vascular diseases, holds potential. Stiff competition in the market remains a woe.

Yahoo | August 19, 2022

Read More 'KOD' Stories Here

KOD Price Returns

1-mo -25.12%
3-mo -6.75%
6-mo 3.12%
1-year -61.42%
3-year 173.38%
5-year N/A
YTD -55.18%
2021 -42.29%
2020 104.18%
2019 913.38%
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7004 seconds.